Pathophysiology and treatment targets in IBD including trial design

About this event

This educational webinar has been developed and organised by the UKCPA.  Johnson & Johnson has provided funding via sponsorship and have had no control or influence over the information or content included in this meeting.  The webinar is intended for UK healthcare professionals only and is FREE to both UKCPA members and verified non-members.

The opening session of the IBD series will deliver essential insights into the pathophysiology of inflammatory bowel disease (IBD). By establishing a strong scientific foundation, this session will enable participants to better understand the therapeutic targets in IBD and mechanisms of action behind advanced therapies and appreciate how these innovations are shaping the current and future treatment landscape for IBD. Attendees will gain knowledge directly applicable to clinical practice, supporting informed therapeutic decisions and enhancing patient care. 

This session will also provide valuable insights into current clinical trial designs in IBD, enabling attendees to critically analyse data from the latest trials.

Aim

The aim of this webinar is to provide attendees with a foundational understanding of inflammatory bowel disease (IBD), including its underlying pathophysiology, key therapeutic targets, and the principles of clinical trial design relevant to its treatment and research.

Target audience

This webinar is intended for advanced level hospital pharmacists in the UK with a specialist focus.

Learning outcomes

After this webinar, attendees should be able to:

• Describe basic pathophysiology of IBD
• Outlines potential therapeutic targets
• Discuss basic clinical trial design

Booking information

Registration will close at midnight on midnight on 26 April 2026 or earlier if maximum capacity is reached. Should this event not reach its minimum number, the UKCPA reserves the right to cancel the webinar.

If you are not a member of UKCPA but wish to attend this event either as a guest or by applying for UKCPA membership in order to attend this webinar as part of your membership package, your guest account or membership application must be completed at least 10 working days in advance of the registration deadline.  Please note that the administration and activation of membership or guest accounts can take up to 7 working days.

Access to the recording of this webinar and any slides made available by the speaker are released as a member benefit.  Guest account attendees are not eligible to access or receive the post event resources.  If you are a guest account holder and wish to access the recording and any resources, please upgrade to full UKCPA membership.

This educational webinar has been developed and organised by the UKCPA.  Johnson & Johnson has provided funding via sponsorship and have had no control or influence over the information or content included in this meeting.  Promotional slides from Johnson and Johnson may be shown at this end of this event.